Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer
Authors
Keywords
-
Journal
Science Advances
Volume 8, Issue 19, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-05-14
DOI
10.1126/sciadv.abn1229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability
- (2021) Sumeet Nayak et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CARM1 regulates replication fork speed and stress response by stimulating PARP1
- (2021) Marie-Michelle Genois et al. MOLECULAR CELL
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
- (2021) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Integrated analysis of multimodal single-cell data
- (2021) Yuhan Hao et al. CELL
- Overcoming Chemotherapy Resistance in SCLC
- (2021) Brett H. Herzog et al. Journal of Thoracic Oncology
- Patient-derived Xenograft Models of Small Cell Lung Cancer for Therapeutic Development
- (2020) V. Vidhyasagar et al. CLINICAL ONCOLOGY
- Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability
- (2020) Sumeet Nayak et al. Science Advances
- Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
- (2020) Jessica J. Lin et al. npj Precision Oncology
- Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors
- (2020) Yasutaka Sakurai et al. CANCER LETTERS
- cGAS suppresses genomic instability as a decelerator of replication forks
- (2020) Hao Chen et al. Science Advances
- A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy
- (2019) Jessica L. Wojtaszek et al. CELL
- Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer
- (2019) Franziska Böttger et al. Cell Reports
- Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
- (2019) Anna F. Farago et al. Cancer Discovery
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
- (2019) Sylvie M. Noordermeer et al. TRENDS IN CELL BIOLOGY
- Sensitive and specific post-call filtering of genetic variants in xenograft and primary tumors
- (2018) Brian K Mannakee et al. BIOINFORMATICS
- Ki-67: more than a proliferation marker
- (2018) Xiaoming Sun et al. CHROMOSOMA
- Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
- (2018) M. Catherine Pietanza et al. JOURNAL OF CLINICAL ONCOLOGY
- SLFN11 Blocks Stressed Replication Forks Independently of ATR
- (2018) Junko Murai et al. MOLECULAR CELL
- Strelka2: fast and accurate calling of germline and somatic variants
- (2018) Sangtae Kim et al. NATURE METHODS
- Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
- (2018) Benjamin J. Drapkin et al. Cancer Discovery
- CellProfiler 3.0: Next-generation image processing for biology
- (2018) Claire McQuin et al. PLOS BIOLOGY
- Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field
- (2018) Juliet Williams Journal of Clinical Medicine
- High speed of fork progression induces DNA replication stress and genomic instability
- (2018) Apolinar Maya-Mendoza et al. NATURE
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion.
- (2018) Zofia Piotrowska et al. Cancer Discovery
- XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data
- (2018) Roelof J. C. Kluin et al. BMC BIOINFORMATICS
- Structural Approach To Identify a Lead Scaffold That Targets the Translesion Synthesis Polymerase Rev1
- (2018) Radha Charan Dash et al. Journal of Chemical Information and Modeling
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Mechanisms of DNA damage, repair, and mutagenesis
- (2017) Nimrat Chatterjee et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer
- (2016) Benjamin H. Lok et al. CLINICAL CANCER RESEARCH
- Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics
- (2016) Dmitry M. Korzhnev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer
- (2016) Kenichi Suda et al. LUNG CANCER
- PolDIP2 interacts with human PrimPol and enhances its DNA polymerase activities
- (2016) Thomas A. Guilliam et al. NUCLEIC ACIDS RESEARCH
- FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
- (2016) Ronglai Shen et al. NUCLEIC ACIDS RESEARCH
- Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
- (2015) Jessian L. Munoz et al. CANCER LETTERS
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor
- (2015) Z. Piotrowska et al. Cancer Discovery
- Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer
- (2015) Kenichi Suda et al. Scientific Reports
- Molecular pathways and therapeutic targets in lung cancer
- (2015) Emma Shtivelman et al. Oncotarget
- Small cell lung cancer: Where do we go from here?
- (2014) Lauren Averett Byers et al. CANCER
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- Human Pol purified with accessory subunits is active in translesion DNA synthesis and complements Pol in cisplatin bypass
- (2014) Y.-S. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- OpenComet: An automated tool for comet assay image analysis
- (2014) Benjamin M. Gyori et al. Redox Biology
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- DNA polymerase -interacting protein 2 is a processivity factor for DNA polymerase during 8-oxo-7,8-dihydroguanine bypass
- (2013) G. Maga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Damage Sensing by the ATM and ATR Kinases
- (2013) A. Marechal et al. Cold Spring Harbor Perspectives in Biology
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff
- (2012) Pablo Cingolani et al. FLY
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
- (2012) G. Zoppoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
- (2012) Koji Yoshimoto et al. Frontiers in Oncology
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer
- (2010) K. Suda et al. CLINICAL CANCER RESEARCH
- Error-prone translesion synthesis mediates acquired chemoresistance
- (2010) K. Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Rev3, the catalytic subunit of Pol , sensitizes drug-resistant lung tumors to chemotherapy
- (2010) J. Doles et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- The Translesion Polymerase Rev3L in the Tolerance of Alkylating Anticancer Drugs
- (2009) W. P. Roos et al. MOLECULAR PHARMACOLOGY
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now